Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
NCT Number: NCT02339870
This randomized clinical trial studies expressive writing in improving the wellbeing or comforting capacity of caregivers of patients with cancer. Expressive writing is a type of intervention that asks people to write about important topics (in this case participants' experience with their spouses'/partners' cancer) and their emotions/feelings surrounding them. Expressive writing, including benefit finding and traumatic disclosure, may be a type of at-home-therapy that caregivers can utilize in an attempt to increase their own wellbeing, offer better comfort to cancer patients, and by association, help cancer patients cope with and manage the cancer experience.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Seattle, Washington, 98109, United States
PRIMARY OBJECTIVES:
I. To test whether one, or both, types of expressive writing impact spouses of cancer survivors' reported emotional wellbeing and reported ability to provide comfort as compared to a control group.
OUTLINE: Patients are randomized to 1 of 2 arms or assigned to a control arm.
ARM I (EXPRESSIVE DISCLOSURE): Participants complete an anonymous 20 minute writing exercise at home on their computer once per week for 2 weeks (days 2, 9, and 16 for a total of 3 sessions). Participants write about their emotions pertaining to managing and providing care for the cancer patient.
ARM II (BENEFIT FINDING): Participants complete an anonymous 20 minute writing exercise at home on their computer once per week for 2 weeks (days 2, 9, and 16 for a total of 3 sessions). Participants write about any benefits that have arisen because of the cancer diagnosis.
ARM III (CONTROL): Participants complete an anonymous 20 minute writing exercise at home on their computer once per week for 2 weeks (days 2, 9, and 16 for a total of 3 sessions). Participants write about an emotionally neutral topic.
After completion of study, participants are followed up at day 17.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Complete expressive disclosure writing
Ancillary studies
Complete writing on an emotionally neutral topic
Time frame: Baseline to day 17
Will be reported pre- to post-test for both treatment groups compared to the control group. Repeated measures analysis of variance (ANOVA) within/between interaction will be used.
Time frame: Baseline to day 17
Compared between women and men in both treatment groups using paired samples t-test.
Time frame: Up to day 17
Will be analyzed using multiple linear regression.
Time frame: Baseline to day 17
Will be compared between traumatic disclosure participants and the control group and between benefit finding participants and the control group using repeated measures ANOVA within/between interaction.
Time frame: Baseline to day 17
Will be compared between women and men in both treatment groups using paired samples t-test.
Time frame: Baseline to day 17
Will be compared between traumatic disclosure participants and the control group and between benefit finding participants and the control group using repeated measures ANOVA within/between group interaction.
Time frame: Baseline to day 17
Will be analyzed using multiple linear regression.
Time frame: Up to day 17
Will be analyzed using multiple linear regression.
Time frame: Up to day 17
Analyzed using linear multiple regression.
Time frame: Up to day 17
Compared between traumatic disclosure and benefit finding groups using post-hoc analyses of repeated measures ANOVA.
Time frame: Up to day 17
Will be analyzed using multiple linear regression.
University of Washington
Other
Caring for Caregivers: Increasing Cancer Caregiver Wellbeing and Comforting Sensitivity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07181629
Behavior, Behavioral Symptoms
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT07522086
Brain Damage, Chronic, Brain Diseases
Ankara, Keçiören, Turkey (Türkiye)
View Trial DetailsNCT07480642
Brain Diseases, Cardiovascular Diseases
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT07314463
Behavior, Behavioral Symptoms
Konya, Selcuklu, Turkey (Türkiye)
View Trial Details